Patents by Inventor Rongrong He

Rongrong He has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11967646
    Abstract: Disclosed are a thin film transistor structure, a display panel and a display device. The thin film transistor structure includes a base, a source electrode, a drain electrode configured to connect to a pixel electrode and a grid electrode. The source electrode, the drain electrode and the grid electrode are provided on the base. and a channel is formed between the source electrode and the drain electrode. The thin film transistor structure further includes an insulating layer and a slow-release electrode. The insulating layer is provided on a side of the source electrode and the drain electrode, and filled in the channel. The slow-release electrode is provided in the insulating layer. At least a part of the slow-release electrode is provided inside the channel.
    Type: Grant
    Filed: June 1, 2023
    Date of Patent: April 23, 2024
    Assignee: HKC CORPORATION LIMITED
    Inventors: Keming Yang, Yizhen Xu, Chunhui Ren, Feng Jiang, Liu He, Qiang Leng, Rongrong Li
  • Publication number: 20240088298
    Abstract: Disclosed are a thin film transistor structure, a display panel and a display device. The thin film transistor structure includes a base, a source electrode, a drain electrode configured to connect to a pixel electrode and a grid electrode. The source electrode, the drain electrode and the grid electrode are provided on the base. and a channel is formed between the source electrode and the drain electrode. The thin film transistor structure further includes an insulating layer and a slow-release electrode. The insulating layer is provided on a side of the source electrode and the drain electrode, and filled in the channel. The slow-release electrode is provided in the insulating layer. At least a part of the slow-release electrode is provided inside the channel.
    Type: Application
    Filed: June 1, 2023
    Publication date: March 14, 2024
    Applicant: HKC CORPORATION LIMITED
    Inventors: Keming YANG, Yizhen XU, Chunhui REN, Feng JIANG, Liu HE, Qiang LENG, Rongrong LI
  • Publication number: 20220227650
    Abstract: An integrated boron removal and flocculation process for treating fracturing wastewater is disclosed. The process comprises: adjusting the pH of the fracturing flowback liquid to be treated to become alkaline and adding thereto an oxidant to carry out a reaction for a certain time period, so that the state of the boron present in the liquid is changed; and then adding a barium salt to the resulting reaction mixture to carry out a further reaction between the barium salt and the boron in the changed state to produce a precipitate. The stability of the flowback liquid is deteriorated by the addition of the oxidant. Suspended solids in the flowback liquid can be removed through adsorption, wrapping, and then settling by the action of the precipitate (a barium salt). The process integrates boron removal and flocculation and enables a boron removal rate of 80% or greater. The contents of the suspended solids and oil present in the fracturing flowback liquid after filtration each can be lowered to less than 5.
    Type: Application
    Filed: August 5, 2020
    Publication date: July 21, 2022
    Applicants: XI'AN SHIYOU UNIVERSITY, CHINA NATIONAL PETROLEUM CORPORATION SAFETY AND ENVIRONMENTAL TECHNOLOGY RESEARCH INSTITUTE CO., LTD
    Inventors: Tao Yu, Chengtun Qu, Jinling Li, Bo Yang, Xiaofei Zhang, Zhen Luo, Rongrong He
  • Publication number: 20220047658
    Abstract: A traditional Chinese medicine (TCM) addition and subtraction prescription for preventing/treating metabolic syndrome and comprises: Poria, Semen Coicis, Rhizoma Dioscoreae, Semen Euryales, and Semen Nelumbinis, and can be used for prevention and/or treatment of various dysmetabolic syndrome and complications, e.g., insulin resistance syndrome, diabetes mellitus, hyperlipemia, fatty liver disease, obesity, atherosclerosis, arterial sclerosis, and hypertension; the components of the TCM addition and subtraction prescription are simple and have no toxic or side effects to human body, without tolerance. The TCM addition and subtraction prescription may be orally administered for a long term, and may be appropriately increased or decreased according to disease condition; it may act to different extents, and would not result in hypoglycemia or hypotension decreased blood glucose or decreased blood pressure below normal range, etc.
    Type: Application
    Filed: November 1, 2021
    Publication date: February 17, 2022
    Inventor: Rongrong HE
  • Patent number: 11208427
    Abstract: The present invention relates to dicaffeoyl spermidine derivative glycosides, a preparation method and a use thereof. The biological activity experiments show that the dicaffeoyl spermidine derivative glycosides of the present invention have anti-oxidative activity and antiviral activity, and their activity are even better than that of a positive control drug, thus can be used as an antioxidant for the prevention and/or treatment of neurodegenerative diseases such as Senile dementia, and as an antiviral agent for the prevention and/or treatment of viral infections.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: December 28, 2021
    Assignee: Jinan University
    Inventors: Hao Gao, Xinsheng Yao, Rongrong He, Guodong Chen, Zhengqun Zhou, Chuanxi Wang, Dan Hu, Hongxia Fan
  • Patent number: 10457702
    Abstract: The present invention relates to dicaffeoyl spermidine cyclized derivatives and a preparation method and use thereof. Biological activity experiments show that the dicaffeoyl spermidine cyclized derivatives of the present invention have anti-Senile dementia activity and antioxidant activity, and their activity are even better than that of a positive control drug, thus suitable for the prevention and treatment of neurodegenerative diseases such as Senile dementia.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: October 29, 2019
    Assignee: Jinan University
    Inventors: Hao Gao, Xinsheng Yao, Rongrong He, Guodong Chen, Zhengqun Zhou, Chuanxi Wang, Dan Hu, Hongxia Fan
  • Publication number: 20190292212
    Abstract: The present invention relates to dicaffeoyl spermidine derivative glycosides, a preparation method and a use thereof. The biological activity experiments show that the dicaffeoyl spermidine derivative glycosides of the present invention have anti-oxidative activity and antiviral activity, and their activity are even better than that of a positive control drug, thus can be used as an antioxidant for the prevention and/or treatment of neurodegenerative diseases such as Senile dementia, and as an antiviral agent for the prevention and/or treatment of viral infections.
    Type: Application
    Filed: January 13, 2017
    Publication date: September 26, 2019
    Inventors: Hao Gao, Xinsheng Yao, Rongrong He, Guodong Chen, Zhengqun Zhou, Chuanxi Wang, Dan Hu, Hongxia Fan
  • Publication number: 20190031701
    Abstract: The present invention relates to dicaffeoyl spermidine cyclized derivatives and a preparation method and use thereof. Biological activity experiments show that the dicaffeoyl spermidine cyclized derivatives of the present invention have anti-Senile dementia activity and antioxidant activity, and their activity are even better than that of a positive control drug, thus suitable for the prevention and treatment of neurodegenerative diseases such as Senile dementia.
    Type: Application
    Filed: January 13, 2017
    Publication date: January 31, 2019
    Applicant: Jinan University
    Inventors: Hao Gao, Xinsheng Yao, Rongrong He, Guodong Chen, Zhengqun Zhou, Chuanxi Wang, Dan Hu, Hongxia Fan
  • Patent number: D915694
    Type: Grant
    Filed: August 14, 2018
    Date of Patent: April 6, 2021
    Assignee: SHENZHEN DEKANG ELECTRONIC CLEANING APPLIANCES CO., LTD.
    Inventor: Rongrong He